Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Chinese Patent Office
Express Scripts
Moodys
Farmers Insurance
Merck
Cerilliant
Argus Health
Accenture

Generated: November 17, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021262

« Back to Dashboard

NDA 021262 describes ALPHAGAN P, which is a drug marketed by Allergan and is included in two NDAs. It is available from one supplier. There are seven patents protecting this drug and two Paragraph IV challenges. Additional details are available on the ALPHAGAN P profile page.

The generic ingredient in ALPHAGAN P is brimonidine tartrate. There are eleven drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the brimonidine tartrate profile page.
Summary for 021262
Tradename:ALPHAGAN P
Applicant:Allergan
Ingredient:brimonidine tartrate
Patents:5
Pharmacology for NDA: 021262
Mechanism of ActionAdrenergic alpha-Agonists
Medical Subject Heading (MeSH) Categories for 021262
Suppliers and Packaging for NDA: 021262
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ALPHAGAN P brimonidine tartrate SOLUTION/DROPS;OPHTHALMIC 021262 NDA Allergan, Inc. 0023-9177 0023-9177-05 1 BOTTLE, DROPPER in 1 CARTON (0023-9177-05) > 5 mL in 1 BOTTLE, DROPPER
ALPHAGAN P brimonidine tartrate SOLUTION/DROPS;OPHTHALMIC 021262 NDA Allergan, Inc. 0023-9177 0023-9177-10 1 BOTTLE, DROPPER in 1 CARTON (0023-9177-10) > 10 mL in 1 BOTTLE, DROPPER

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION/DROPS;OPHTHALMICStrength0.15%
Approval Date:Mar 16, 2001TE:ATRLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:Jan 10, 2022Product Flag?Substance Flag?Delist Request?Y
Patent:➤ Try a Free TrialPatent Expiration:Jan 18, 2022Product Flag?Substance Flag?Delist Request?Y
Patent:➤ Try a Free TrialPatent Expiration:Jan 28, 2022Product Flag?Substance Flag?Delist Request?Y

Expired US Patents for NDA 021262

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Allergan ALPHAGAN P brimonidine tartrate SOLUTION/DROPS;OPHTHALMIC 021262-001 Mar 16, 2001 ➤ Try a Free Trial ➤ Try a Free Trial
Allergan ALPHAGAN P brimonidine tartrate SOLUTION/DROPS;OPHTHALMIC 021262-001 Mar 16, 2001 ➤ Try a Free Trial ➤ Try a Free Trial
Allergan ALPHAGAN P brimonidine tartrate SOLUTION/DROPS;OPHTHALMIC 021262-001 Mar 16, 2001 ➤ Try a Free Trial ➤ Try a Free Trial
Allergan ALPHAGAN P brimonidine tartrate SOLUTION/DROPS;OPHTHALMIC 021262-001 Mar 16, 2001 ➤ Try a Free Trial ➤ Try a Free Trial
Allergan ALPHAGAN P brimonidine tartrate SOLUTION/DROPS;OPHTHALMIC 021262-001 Mar 16, 2001 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Cantor Fitzgerald
Moodys
Deloitte
McKinsey
Chinese Patent Office
Covington
Express Scripts
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.